Assessing The Best Biotech ETFs
While the biotech sector has outperformed the broader market over the past 12 months, investing in this sector can be risky. As such, the author… Read More »Assessing The Best Biotech ETFs
While the biotech sector has outperformed the broader market over the past 12 months, investing in this sector can be risky. As such, the author… Read More »Assessing The Best Biotech ETFs
Today’s article details two stocks that, according to both analysts at JPMorgan as well as the broader Wall Street analyst consensus, are primed for strong… Read More »2 Stocks Where Analysts See Strong Gains Ahead
It appears that a mystery investor has recently spent more than $300 million buying up tens of thousands of S&P 500 call spreads that expire… Read More »A Mystery Investor’s Massive Post-Election Bet
The group of stocks that are the focus of today’s article have been experiencing an incredible run-up this year, with their outperformance likely attributable to… Read More »These Biden-Boosted Stocks Could Continue To Be Winners Even If He Loses
A deluge of data for various COVID-19 vaccine candidates is expected in the next month or two, and today’s article notes that strategists at Goldman… Read More »Bracing For COVID Vaccine Results — Encouraging Or Disappointing — In The Coming Weeks
“Smart investors will look for biotech stocks that have drug pipelines full of good prospects, as well as balance sheets strong enough to withstand any… Read More »Strong Drug Pipelines (And Balance Sheets) May Make These The Best Biotech Stocks To Buy Right Now
Today’s article highlights a plethora of new stocks to watch in the biotech, tech, cleantech, psychedelics and cannabis spaces, among others. In regards to the… Read More »New Stocks To Watch In Biotech, Cleantech, Psychedelics & More
Despite biotech’s outperformance year-to-date, the authors of today’s article still see the industry as attractive – and they outline three key strategic themes driving their… Read More »The Investment Thesis For Biotech (And Especially Biopharma)
After an initial analysis of clinical data back in May failed to demonstrate a statistically significant impact on the biomarkers associated with the disease, a… Read More »This Buy-Rated Biotech With An Effective Alzheimer’s Drug Has Upside Potential Of Over 100%
The four penny stocks highlighted in today’s article are all biopharmaceutical/biotech companies, they can all be bought for under $4, and they all have important… Read More »Which Of These Biotech Penny Stocks Are Worth The Under-$4 Price Of Admission?